1. Market Research
  2. > Pharmaceutical Market Trends
  3. > BBMI – Penang Pharmaceutical Plant Expansion – Malaysia - Construction Project Profile

Synopsis

The "BBMI – Penang Pharmaceutical Plant Expansion – Malaysia - Construction Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts.

The "BBMI – Penang Pharmaceutical Plant Expansion – Malaysia - Construction Project Profile" is part of World Market Intelligence's database of 25,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $50 million and key contact details for project managers, owners, consultants, contractors and bidders.

Summary

World Market Intelligence's "BBMI – Penang Pharmaceutical Plant Expansion – Malaysia - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the BBMI – Penang Pharmaceutical Plant Expansion – Malaysia construction project.

World Market Intelligence's "BBMI – Penang Pharmaceutical Plant Expansion – Malaysia - Construction Project Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope

This report provides details on the BBMI – Penang Pharmaceutical Plant Expansion – Malaysia - Construction Project Profile including:
• Project description, overview and location.
• Ownership structure, funding status and key funding news for the project.
• Information on related projects and tendering information.
• Key project contact details.

Reasons To Buy

• Gain insight into the project.
• Monitor the latest project developments.
• Identify key project contacts.

Table Of Contents

BBMI - Penang Pharmaceutical Plant Expansion - Malaysia - Construction Project Profile
Table of Contents

1 Project Scope
1.1 Overview
1.2 Location
1.3 Project Owner and Funding
1.3.1 Funding
1.4 Project Description
1.5 Project Background
1.6 Latest Update
2 Tender Info
3 Key Contacts
3.1 Project Owner
4 Appendix
4.1 About World Market Intelligence
4.2 Disclaimer

List of Tables

Table 1: BBMI - Penang Pharmaceutical Plant Expansion - Malaysia, Key Facts
Table 2: BBMI - Penang Pharmaceutical Plant Expansion - Malaysia, Location Details
Table 3: BBMI - Penang Pharmaceutical Plant Expansion - Malaysia, Funding Details
Table 4: BBMI - Penang Pharmaceutical Plant Expansion - Malaysia , Tender Info
Table 5: BBMI - Penang Pharmaceutical Plant Expansion - Malaysia, Project Owner Contacts

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

  • $ 6995
  • Industry report
  • January 2017
  • by GBI Research

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation Summary Melanoma is a type of cancer that begins in the ...

North America Vision Care Market Outlook to 2022

North America Vision Care Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

North America Vision Care Market Outlook to 2022 Summary GlobalData’s new report, "North America Vision Care Market Outlook to 2022", provides key market data on the North America Vision Care market. ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.